vs

Side-by-side financial comparison of DBV Technologies S.A. (DBVT) and 22nd Century Group, Inc. (XXII). Click either name above to swap in a different company.

22nd Century Group, Inc. is the larger business by last-quarter revenue ($3.5M vs $2.8M, roughly 1.3× DBV Technologies S.A.). 22nd Century Group, Inc. runs the higher net margin — -79.4% vs -1195.5%, a 1116.1% gap on every dollar of revenue. On growth, DBV Technologies S.A. posted the faster year-over-year revenue change (158.8% vs -12.0%). 22nd Century Group, Inc. produced more free cash flow last quarter ($2.7M vs $-32.6M). Over the past eight quarters, DBV Technologies S.A.'s revenue compounded faster (12.4% CAGR vs -26.1%).

DBV Technologies SA is a publicly owned French biopharmaceutical firm headquartered in Bagneux, France. DBV Technologies is known for developing "Viaskin" technology for administering allergens or antigens to intact skin while avoiding any transfer to the blood. Viaskin Peanut clinical development has received Fast Track designation from the US Food and Drug Administration.

22nd Century Media was an American media company based in the suburbs of Chicago. The company was founded in 2005 and at one time published 14 weekly community newspapers. The publications had roughly 160,000 subscribers.

DBVT vs XXII — Head-to-Head

Bigger by revenue
XXII
XXII
1.3× larger
XXII
$3.5M
$2.8M
DBVT
Growing faster (revenue YoY)
DBVT
DBVT
+170.8% gap
DBVT
158.8%
-12.0%
XXII
Higher net margin
XXII
XXII
1116.1% more per $
XXII
-79.4%
-1195.5%
DBVT
More free cash flow
XXII
XXII
$35.3M more FCF
XXII
$2.7M
$-32.6M
DBVT
Faster 2-yr revenue CAGR
DBVT
DBVT
Annualised
DBVT
12.4%
-26.1%
XXII

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
DBVT
DBVT
XXII
XXII
Revenue
$2.8M
$3.5M
Net Profit
$-33.2M
$-2.8M
Gross Margin
Operating Margin
-1235.7%
-79.2%
Net Margin
-1195.5%
-79.4%
Revenue YoY
158.8%
-12.0%
Net Profit YoY
-8.9%
38.4%
EPS (diluted)
$-0.24
$-36.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DBVT
DBVT
XXII
XXII
Q4 25
$3.5M
Q3 25
$2.8M
$4.0M
Q2 25
$1.5M
$4.1M
Q1 25
$6.0M
Q4 24
$4.0M
Q3 24
$5.9M
Q2 24
$1.2M
$7.9M
Q1 24
$1.4M
$6.5M
Net Profit
DBVT
DBVT
XXII
XXII
Q4 25
$-2.8M
Q3 25
$-33.2M
$5.5M
Q2 25
$-41.9M
$-3.4M
Q1 25
$-4.3M
Q4 24
$-4.6M
Q3 24
$-3.8M
Q2 24
$-33.1M
$-1.1M
Q1 24
$-27.3M
$-5.7M
Gross Margin
DBVT
DBVT
XXII
XXII
Q4 25
Q3 25
36.3%
Q2 25
29.9%
Q1 25
Q4 24
Q3 24
47.8%
Q2 24
51.3%
Q1 24
Operating Margin
DBVT
DBVT
XXII
XXII
Q4 25
-79.2%
Q3 25
-1235.7%
-80.1%
Q2 25
-2806.2%
-73.0%
Q1 25
-43.1%
Q4 24
-101.8%
Q3 24
-56.8%
Q2 24
-2914.9%
-25.8%
Q1 24
-2029.7%
-68.5%
Net Margin
DBVT
DBVT
XXII
XXII
Q4 25
-79.4%
Q3 25
-1195.5%
136.8%
Q2 25
-2858.4%
-83.4%
Q1 25
-72.7%
Q4 24
-113.3%
Q3 24
-63.2%
Q2 24
-2852.4%
-14.0%
Q1 24
-1943.5%
-88.7%
EPS (diluted)
DBVT
DBVT
XXII
XXII
Q4 25
$-36.48
Q3 25
$-0.24
$-0.28
Q2 25
$-0.31
$-13.61
Q1 25
$-2.50
Q4 24
$-42962.00
Q3 24
$-1760.26
Q2 24
$-0.34
$-593.72
Q1 24
$-0.28
$-395.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DBVT
DBVT
XXII
XXII
Cash + ST InvestmentsLiquidity on hand
$69.8M
$7.1M
Total DebtLower is stronger
$708.0K
Stockholders' EquityBook value
$52.9M
$15.8M
Total Assets
$110.5M
$27.0M
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DBVT
DBVT
XXII
XXII
Q4 25
$7.1M
Q3 25
$69.8M
$4.8M
Q2 25
$103.2M
$3.1M
Q1 25
$1.1M
Q4 24
$4.4M
Q3 24
$5.3M
Q2 24
$66.2M
$1.3M
Q1 24
$101.5M
$1.5M
Total Debt
DBVT
DBVT
XXII
XXII
Q4 25
$708.0K
Q3 25
Q2 25
$3.2M
Q1 25
$3.9M
Q4 24
$6.7M
Q3 24
$7.0M
Q2 24
$7.5M
Q1 24
$14.7M
Stockholders' Equity
DBVT
DBVT
XXII
XXII
Q4 25
$15.8M
Q3 25
$52.9M
$18.4M
Q2 25
$86.2M
$5.6M
Q1 25
$3.6M
Q4 24
$4.0M
Q3 24
$3.5M
Q2 24
$79.1M
$-955.0K
Q1 24
$111.7M
$-11.6M
Total Assets
DBVT
DBVT
XXII
XXII
Q4 25
$27.0M
Q3 25
$110.5M
$32.4M
Q2 25
$143.4M
$22.4M
Q1 25
$21.5M
Q4 24
$21.7M
Q3 24
$26.2M
Q2 24
$114.2M
$24.1M
Q1 24
$145.9M
$24.6M
Debt / Equity
DBVT
DBVT
XXII
XXII
Q4 25
0.04×
Q3 25
Q2 25
0.57×
Q1 25
1.08×
Q4 24
1.66×
Q3 24
2.02×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DBVT
DBVT
XXII
XXII
Operating Cash FlowLast quarter
$-32.4M
$2.7M
Free Cash FlowOCF − Capex
$-32.6M
$2.7M
FCF MarginFCF / Revenue
-1173.5%
77.3%
Capex IntensityCapex / Revenue
4.2%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-138.3M
$-7.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DBVT
DBVT
XXII
XXII
Q4 25
$2.7M
Q3 25
$-32.4M
$-4.0M
Q2 25
$-33.9M
$-3.5M
Q1 25
$-3.0M
Q4 24
$-4.4M
Q3 24
$-3.0M
Q2 24
$-35.1M
$-4.7M
Q1 24
$-34.7M
$-2.3M
Free Cash Flow
DBVT
DBVT
XXII
XXII
Q4 25
$2.7M
Q3 25
$-32.6M
$-4.0M
Q2 25
$-33.9M
$-3.5M
Q1 25
$-3.0M
Q4 24
Q3 24
$-3.0M
Q2 24
$-35.8M
$-4.8M
Q1 24
$-36.0M
$-2.3M
FCF Margin
DBVT
DBVT
XXII
XXII
Q4 25
77.3%
Q3 25
-1173.5%
-100.3%
Q2 25
-2316.5%
-85.9%
Q1 25
-50.1%
Q4 24
Q3 24
-51.2%
Q2 24
-3084.0%
-60.1%
Q1 24
-2560.6%
-35.0%
Capex Intensity
DBVT
DBVT
XXII
XXII
Q4 25
0.5%
Q3 25
4.2%
0.1%
Q2 25
2.2%
0.7%
Q1 25
0.2%
Q4 24
0.0%
Q3 24
1.2%
Q2 24
63.0%
0.8%
Q1 24
94.9%
0.1%
Cash Conversion
DBVT
DBVT
XXII
XXII
Q4 25
Q3 25
-0.73×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons